Presentation is loading. Please wait.

Presentation is loading. Please wait.

Histopathologic features (all images at ×10 magnification).

Published byRatna Makmur Modified over 5 years ago

Similar presentations

Presentation on theme: "Histopathologic features (all images at ×10 magnification)."— Presentation transcript:

1 Histopathologic features (all images at ×10 magnification).
Histopathologic features (all images at ×10 magnification). A, luxol–hematoxylin and eosin (H&E) stain from right frontal lesion, showing a central blood vessel with mild lymphocytic cuffing (arrows), area of severe astrocytic gliosis (bottom left), sheets of macrophages (bottom right, arrowheads), and residual myelin (blue, top left). B, immunohistochemistry for CD68, labeling macrophages (arrows). C, CD45 stain revealing lymphocytes (arrow). D and E, CD4 and CD8 stains, respectively, showing a mixture of T-helper and T-cytotoxic cells. F, luxol–H&E stain from left temporoparietal lesion, showing sheets of macrophages in the bottom left of the image, surrounded by residual myelin (blue) in white matter. Catherine Maurice et al. Cancer Immunol Res 2015;3: ©2015 by American Association for Cancer Research

Download ppt "Histopathologic features (all images at ×10 magnification)."

Similar presentations

Histogenic analysis confirms prostate cancer metastasis to lung.

Histogenic analysis confirms prostate cancer metastasis to lung.
Immunologic effects of F16-IL2 therapy.

Immunologic effects of F16-IL2 therapy.
Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease by Marijke R. Canninga-van Dijk, Hanneke.

Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease by Marijke R. Canninga-van Dijk, Hanneke.
by Thomas S. Uldrick, and Richard F. Little

by Thomas S. Uldrick, and Richard F. Little
Clinical response to F16-IL2 and LDAC in patients with AML bone marrow involvement. Clinical response to F16-IL2 and LDAC in patients with AML bone marrow.

Clinical response to F16-IL2 and LDAC in patients with AML bone marrow involvement. Clinical response to F16-IL2 and LDAC in patients with AML bone marrow.
Intravascular Large B Cell Lymphoma Presenting as Transient Erythema Nodosum-Like Lesions and Fever  David J. Tsoulis, MD, Danny Ghazarian, MD, Eugenia.

Intravascular Large B Cell Lymphoma Presenting as Transient Erythema Nodosum-Like Lesions and Fever  David J. Tsoulis, MD, Danny Ghazarian, MD, Eugenia.
Figure Neuroimaging and pathology

Figure Neuroimaging and pathology
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
TIE2hi/VEGFAhi TEMs are present in the TMEM

TIE2hi/VEGFAhi TEMs are present in the TMEM
IHC staining of FFPE esophageal tissues in tissue microarrays (×20).

IHC staining of FFPE esophageal tissues in tissue microarrays (×20).
Case 5 (type 3). Case 5 (type 3). A and B, Postmortem axial (A) and coronal (B) T2-weighted images show atrophied cerebellar cortices with dilation of.

Case 5 (type 3). Case 5 (type 3). A and B, Postmortem axial (A) and coronal (B) T2-weighted images show atrophied cerebellar cortices with dilation of.
Figure 1 Histopathologic features of a chronic active and a chronic plaque in the MS brain Histopathologic features of a chronic active and a chronic plaque.

Figure 1 Histopathologic features of a chronic active and a chronic plaque in the MS brain Histopathologic features of a chronic active and a chronic plaque.
Figure 1 Muscle biopsy images demonstrating a pauci-immune necrotizing autoimmune myopathy in illustrative cases 1 and 2 (A–D) Case 1 deltoid muscle. Muscle.

Figure 1 Muscle biopsy images demonstrating a pauci-immune necrotizing autoimmune myopathy in illustrative cases 1 and 2 (A–D) Case 1 deltoid muscle. Muscle.
Representative multiplex immunofluorescence image of synovial sarcoma with increased PD-L1/PD-1/CD8 cell densities at the tumor-invasive margin demonstrating.

Representative multiplex immunofluorescence image of synovial sarcoma with increased PD-L1/PD-1/CD8 cell densities at the tumor-invasive margin demonstrating.
Figure Brain MRI and biopsy specimens from the pontine lesion

Figure Brain MRI and biopsy specimens from the pontine lesion
Figure Nuclear Nrf2 expression after fumarate therapy A new left occipital fluid-attenuated inversion recovery hyperintense (A), T1 hypointense (B), and.

Figure Nuclear Nrf2 expression after fumarate therapy A new left occipital fluid-attenuated inversion recovery hyperintense (A), T1 hypointense (B), and.
Figure 2 Histochemical and immunohistochemical staining and electron microscopic examination of structures in the brain biopsy Hematoxylin & eosin staining.

Figure 2 Histochemical and immunohistochemical staining and electron microscopic examination of structures in the brain biopsy Hematoxylin & eosin staining.
Figure 4 Neuropathology of MOG and AQP4 antibody–associated demyelinating lesions in the brain The biopsy specimen revealed a small actively demyelinating.

Figure 4 Neuropathology of MOG and AQP4 antibody–associated demyelinating lesions in the brain The biopsy specimen revealed a small actively demyelinating.
Figure MRI and neuropathologic characteristics of the tumefactive demyelinating lesion in our patient MRI and neuropathologic characteristics of the tumefactive.

Figure MRI and neuropathologic characteristics of the tumefactive demyelinating lesion in our patient MRI and neuropathologic characteristics of the tumefactive.
Figure 4 Representative images of skin biopsy sample

Figure 4 Representative images of skin biopsy sample

Similar presentations

Ads by Google